Leanne Marsay

819 total citations
15 papers, 310 citations indexed

About

Leanne Marsay is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Leanne Marsay has authored 15 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 8 papers in Microbiology and 6 papers in Infectious Diseases. Recurrent topics in Leanne Marsay's work include Bacterial Infections and Vaccines (8 papers), Pneumonia and Respiratory Infections (7 papers) and Tuberculosis Research and Epidemiology (4 papers). Leanne Marsay is often cited by papers focused on Bacterial Infections and Vaccines (8 papers), Pneumonia and Respiratory Infections (7 papers) and Tuberculosis Research and Epidemiology (4 papers). Leanne Marsay collaborates with scholars based in United Kingdom, United States and Norway. Leanne Marsay's co-authors include Helen McShane, Kristin Griffiths, Hazel Poyntz, Elena Stylianou, Andrew J. Pollard, Christine S. Rollier, Anna M. Checkley, Helen A. Fletcher, Christina Dold and Iman Satti and has published in prestigious journals such as PLoS ONE, Scientific Reports and The Journal of Infectious Diseases.

In The Last Decade

Leanne Marsay

15 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leanne Marsay United Kingdom 10 178 154 123 86 50 15 310
Maria Nasso Italy 8 90 0.5× 157 1.0× 197 1.6× 185 2.2× 48 1.0× 11 413
Obondo James Sande Uganda 8 127 0.7× 102 0.7× 101 0.8× 53 0.6× 121 2.4× 26 316
Lucero A. Ramón‐Luing Mexico 14 171 1.0× 91 0.6× 137 1.1× 90 1.0× 117 2.3× 40 425
Michele Tomasicchio South Africa 12 220 1.2× 144 0.9× 127 1.0× 54 0.6× 36 0.7× 21 398
Ranjna Madan-Lala United States 8 231 1.3× 172 1.1× 191 1.6× 20 0.2× 107 2.1× 8 405
Adeliane Castro da Costa Brazil 10 189 1.1× 106 0.7× 181 1.5× 19 0.2× 92 1.8× 23 371
Jenny Li United States 7 102 0.6× 92 0.6× 53 0.4× 40 0.5× 93 1.9× 27 285
Sara Marchi Italy 10 107 0.6× 133 0.9× 41 0.3× 155 1.8× 102 2.0× 15 301
Justine Oliva France 13 172 1.0× 312 2.0× 55 0.4× 36 0.4× 69 1.4× 16 469
Agnès Petit‐Camurdan France 8 87 0.5× 161 1.0× 106 0.9× 39 0.5× 105 2.1× 9 352

Countries citing papers authored by Leanne Marsay

Since Specialization
Citations

This map shows the geographic impact of Leanne Marsay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leanne Marsay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leanne Marsay more than expected).

Fields of papers citing papers by Leanne Marsay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leanne Marsay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leanne Marsay. The network helps show where Leanne Marsay may publish in the future.

Co-authorship network of co-authors of Leanne Marsay

This figure shows the co-authorship network connecting the top 25 collaborators of Leanne Marsay. A scholar is included among the top collaborators of Leanne Marsay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leanne Marsay. Leanne Marsay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Dold, Christina, Leanne Marsay, Laura Silva-Reyes, et al.. (2023). An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal disease. Science Translational Medicine. 15(701). eade3901–eade3901. 2 indexed citations
3.
Marsay, Leanne, Christina Dold, Gavin K. Paterson, et al.. (2022). Viral vectors expressing group B meningococcal outer membrane proteins induce strong antibody responses but fail to induce functional bactericidal activity. Journal of Infection. 84(5). 658–667. 3 indexed citations
4.
Marsay, Leanne, Christina Dold, Andrew J. Pollard, et al.. (2022). Application of a Neisseria meningitidis antigen microarray to identify candidate vaccine proteins from a human Phase I clinical trial. Vaccine. 40(28). 3835–3842. 5 indexed citations
5.
Rollier, Christine S., Christina Dold, Leanne Marsay, et al.. (2022). Human B Cell Responses to Dominant and Subdominant Antigens Induced by a Meningococcal Outer Membrane Vesicle Vaccine in a Phase I Trial. mSphere. 7(1). e0067421–e0067421. 10 indexed citations
6.
Maier, Rebecca, Bilal Bawamia, Karim Bennaceur, et al.. (2020). Telomerase Activation to Reverse Immunosenescence in Elderly Patients With Acute Coronary Syndrome: Protocol for a Randomized Pilot Trial. JMIR Research Protocols. 9(9). e19456–e19456. 16 indexed citations
7.
Wheeler, Jun X., Hannah Chan, Leanne Marsay, et al.. (2019). Immunogenicity profiling of protein antigens from capsular group B Neisseria meningitidis. Scientific Reports. 9(1). 6843–6843. 21 indexed citations
8.
Marsay, Leanne, Heiko A. Schiffter, Robert Carlisle, et al.. (2017). Alternative vaccine administration by powder injection: Needle-free dermal delivery of the glycoconjugate meningococcal group Y vaccine. PLoS ONE. 12(8). e0183427–e0183427. 9 indexed citations
10.
Marsay, Leanne, Christina Dold, Manish Sadarangani, et al.. (2016). Impact of Reducing Complement Inhibitor Binding on the Immunogenicity of Native Neisseria meningitidis Outer Membrane Vesicles. PLoS ONE. 11(2). e0148840–e0148840. 6 indexed citations
11.
Marsay, Leanne, Christina Dold, Christopher Green, et al.. (2015). A novel meningococcal outer membrane vesicle vaccine with constitutive expression of FetA: A phase I clinical trial. Journal of Infection. 71(3). 326–337. 43 indexed citations
12.
Poyntz, Hazel, Elena Stylianou, Kristin Griffiths, et al.. (2014). Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis. Tuberculosis. 94(3). 226–237. 64 indexed citations
13.
Rollier, Christine S., Christina Dold, Leanne Marsay, Manish Sadarangani, & Andrew J. Pollard. (2014). The capsular group B meningococcal vaccine, 4CMenB: clinical experience and potential efficacy. Expert Opinion on Biological Therapy. 15(1). 131–142. 15 indexed citations
14.
Marsay, Leanne, Magali Matsumiya, Rachel Tanner, et al.. (2013). Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb). Tuberculosis. 93(5). 551–557. 38 indexed citations
15.
Meyer, Joel N., Iman Satti, Leanne Marsay, et al.. (2013). Evaluation of a Human BCG Challenge Model to Assess Antimycobacterial Immunity Induced by BCG and a Candidate Tuberculosis Vaccine, MVA85A, Alone and in Combination. The Journal of Infectious Diseases. 209(8). 1259–1268. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026